IDIQ: chemistry, manufacturing, and control (CMC) and related services for drug products (trnd 3)
Active Awarded Last action
- Contract number
- 75N95024D00013
- Awardee
-
Advanced Bioscience Laboratories, Inc. UEI MK4QC9EKZXG8
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products Pre-Solicitation · 75N95023R00037 · Posted May 30, 2023
- Last date to order 32% complete
- IDV ceiling
- $49,885,703.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 8 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute on Drug Abuse awarded a multiple-award indefinite-delivery contract to Advanced Bioscience Laboratories, Inc., with a ceiling of $49,885,703.00 and an award date of August 1, 2024. This IDIQ is structured to provide chemistry, manufacturing, and control (CMC) and related services for drug products, executing under Executive Order 14398. The contract runs through July 31, 2031.
Advanced Bioscience Laboratories, Inc., is a contract research and manufacturing organization specializing in biopharmaceutical development services, including cGMP manufacturing of vaccines and biologics, process development, analytical testing, stability studies, and quality assurance. The company provides preclinical and clinical development support across infectious disease countermeasures, gene therapies, oncolytics, and immunotherapies.
Place of performance is not specified in the source. The originating solicitation, posted May 30, 2023, with a June 14, 2023 due date, sought CMC and related services supporting drug product development under the parent master IDIQ framework. This is one of multiple awards issued under the same CMC and Related Services program.
The source does not surface recent task-order activity issued under this specific IDIQ.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N95024D00013?
75N95024D00013 was awarded to Advanced Bioscience Laboratories, Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 1, 2024.
How much is contract 75N95024D00013 worth?
75N95024D00013's own ceiling is $49,885,703.
Who can order from contract 75N95024D00013?
75N95024D00013 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N95024D00013 part of a contract vehicle?
Yes. 75N95024D00013 is part of Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products.
Was contract 75N95024D00013 competed?
The extent of competition for 75N95024D00013 was full and open competition. The government received 8 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV